| ADT | androgen deprivation therapy |
| AR | androgen receptor |
| CRPC | castration-resistant prostate cancer |
| DHT | dihydrotestosterone |
| EMT | epithelial-to-mesenchymal transition |
| FBS | fetal bovine serum |
| IL-6 | interleukin-6 |
| LNCaP | lymph node carcinoma of the prostate |
| NE | neuroendocrine |
| NED | neuroendocrine differentiation |
| NSE | neuron-specific enolase |
| PCa | prostate cancer |
| PSA | prostate-specific antigen |
| SCC | small cell carcinoma |
| TME | tumor microenvironment |
| t-NEPC | therapy-induced neuroendocrine prostate cancer |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.